David Shibata, MD
Surgical Oncology · Memphis, TNNPI 1700892387
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AstraZeneca at 35.8% of the total. That places this record below the midpoint for surgical oncology clinicians in TN, where the typical reported total is $1,386.
Across 29 payments — averaging $39.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$406
- Taiho Oncology, Inc.$161
- Genentech USA, Inc.$125
- Intuitive Surgical$122
- Tempus AI, Inc$106
- Medtronic$81
- plus $134 from 5 others
What the payments were for
- Speaking & faculty fees$43138%
- Travel & lodging$16915%
- Food & beverage$53647%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $406 |
| Taiho Oncology, Inc. | 4 | $161 |
| Genentech USA, Inc. | 1 | $125 |
| Intuitive Surgical | 1 | $122 |
| Tempus AI, Inc | 6 | $106 |
| Medtronic | 2 | $81 |
| Integra Lifesciences Corporation | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 1 | $35 |
| Acera Surgical, Inc. | 1 | $21 |
| Acrotech Biopharma Inc. | 1 | $15 |
| Ambu Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avastin$125
- Da Vinci Surgical System$122
How this compares
$1,136 in reported general payments places this provider in the 45th percentile of 53 surgical oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Memphis
- Richard FineMemphis$8K
- Richard GilmoreMemphis$3K
- Miriam TsaoMemphis$2K
- Ashley HendrixMemphis$2K
- Shuja AhmedMemphis$2K
- Keli TurnerMemphis$2K
- Ian SolskyMemphis$2K
- Nicholas EconomidesMemphis$599
- Chelsea OlsonMemphis$398
- Christine MrozMemphis$136
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.